Unlike before, beneficiaries will now be able to choose...
efficacy data
Bharat Biotech is awaiting approval of its regulatory documentation...
T.S. Singh Deo founded his request on two concerns:...
An ICMR scientist said Covaxin's "clinical trial mode" roll-out...
